We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.7B
AUM Growth
+$950M
Cap. Flow
+$723M
Cap. Flow %
5.27%
Top 10 Hldgs %
11.77%
Holding
2,830
New
300
Increased
700
Reduced
765
Closed
275

Top Buys

Rank Stock Value
1
GLW icon
Corning
GLW
+$45.6M
2
ACN icon
Accenture
ACN
+$41.1M
3
OA
Orbital ATK, Inc.
OA
+$33.7M
4
HRL icon
Hormel Foods
HRL
+$32.9M
5
PCAR icon
PACCAR
PCAR
+$32.7M

Sector Composition

Rank Sector Weight
1 Technology 15.82%
2 Healthcare 14.78%
3 Industrials 11.92%
4 Financials 9.77%
5 Consumer Discretionary 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPZ
2401
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
-17,887
Closed -$753K
AGN
2402
DELISTED
Allergan Inc
AGN
-290,258
Closed -$61.7M
GCVRZ
2403
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$0 ﹤0.01%
100
EMCG
2404
DELISTED
WisdomTree Emerging Markets Consumer Growth Fund
EMCG
-12,000
Closed -$299K
IMS
2405
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
-182
Closed -$4K

Similar funds

Glenmede Trust's Q1 2015 Portfolio in Review

As of Q1 2015, Glenmede Trust held 2,830 positions worth $13.7B, up 7.4% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Glenmede Trust deployed $723M of net new capital in Q1 2015, opening 300 new positions and adding to 700 existing holdings. Its largest new stake was Qorvo: 411,283 shares worth $32.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was NOV, an estimated $18.7M trimmed.

  • Glenmede Trust's largest Q1 2015 buy was Qorvo: 411,283 shares worth $32.8M.
  • Glenmede Trust added most to Corning in Q1 2015, an estimated $45.6M increase.
  • Glenmede Trust's biggest Q1 2015 reduction was NOV, cutting an estimated $18.7M.
  • Glenmede Trust fully exited Allergan Inc in Q1 2015, selling an estimated $61.7M.
  • Glenmede Trust's ten largest holdings make up 12% of its $13.7B portfolio in Q1 2015.
  • Glenmede Trust opened 300 new positions and closed 275 in Q1 2015.
  • Glenmede Trust's portfolio value rose 7.4% quarter-over-quarter to $13.7B.

Based on Glenmede Trust's 13F filing for Q1 2015, filed 29 Apr 2015.